Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp1
|
ENSMUSG00000030067.11 | forkhead box P1 |
Foxj2
|
ENSMUSG00000003154.9 | forkhead box J2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_122826334_122826673 | Foxj2 | 172 | 0.897306 | 0.90 | 1.5e-02 | Click! |
chr6_122818862_122819013 | Foxj2 | 977 | 0.330103 | -0.88 | 2.1e-02 | Click! |
chr6_122819451_122819712 | Foxj2 | 333 | 0.713924 | -0.87 | 2.3e-02 | Click! |
chr6_122819078_122819314 | Foxj2 | 718 | 0.438264 | -0.81 | 5.1e-02 | Click! |
chr6_122824535_122825042 | Foxj2 | 1887 | 0.183342 | 0.72 | 1.0e-01 | Click! |
chr6_99280984_99281139 | Foxp1 | 14529 | 0.270519 | -0.98 | 5.2e-04 | Click! |
chr6_99265750_99265901 | Foxp1 | 690 | 0.800379 | -0.97 | 1.5e-03 | Click! |
chr6_98920465_98920616 | Foxp1 | 9245 | 0.271528 | 0.97 | 1.7e-03 | Click! |
chr6_99301546_99301706 | Foxp1 | 35094 | 0.202665 | -0.96 | 1.9e-03 | Click! |
chr6_99210315_99210483 | Foxp1 | 37937 | 0.209156 | 0.96 | 2.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_58157498_58157649 | 18.40 |
Gm16277 |
predicted gene 16277 |
46566 |
0.16 |
chr4_41630291_41630458 | 16.83 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
1270 |
0.29 |
chr8_91379183_91379600 | 15.77 |
Fto |
fat mass and obesity associated |
11164 |
0.15 |
chr4_117342819_117343008 | 15.27 |
Rnf220 |
ring finger protein 220 |
32544 |
0.12 |
chr2_103870054_103870389 | 14.12 |
Gm13876 |
predicted gene 13876 |
18103 |
0.09 |
chr15_7088669_7089236 | 13.69 |
Lifr |
LIF receptor alpha |
1662 |
0.5 |
chr3_101881841_101882004 | 13.23 |
Slc22a15 |
solute carrier family 22 (organic anion/cation transporter), member 15 |
4035 |
0.26 |
chr1_165609107_165609258 | 12.87 |
Mpzl1 |
myelin protein zero-like 1 |
364 |
0.78 |
chr6_128523521_128524414 | 12.65 |
Pzp |
PZP, alpha-2-macroglobulin like |
2736 |
0.13 |
chr9_105878487_105878719 | 12.47 |
Col6a5 |
collagen, type VI, alpha 5 |
3203 |
0.27 |
chr5_134941937_134942100 | 12.34 |
Mettl27 |
methyltransferase like 27 |
1556 |
0.18 |
chr1_167320339_167320493 | 11.86 |
Tmco1 |
transmembrane and coiled-coil domains 1 |
6279 |
0.12 |
chr7_27478150_27478347 | 11.58 |
Sertad3 |
SERTA domain containing 3 |
4480 |
0.1 |
chr5_104086712_104086871 | 11.13 |
Gm17660 |
predicted gene, 17660 |
9183 |
0.11 |
chr1_165616718_165617070 | 11.04 |
Mpzl1 |
myelin protein zero-like 1 |
2915 |
0.15 |
chr10_8086797_8087175 | 10.97 |
Gm48614 |
predicted gene, 48614 |
65694 |
0.11 |
chr16_22439730_22439912 | 10.93 |
Etv5 |
ets variant 5 |
102 |
0.97 |
chr12_84930852_84931021 | 10.69 |
Gm17193 |
predicted gene 17193 |
7424 |
0.12 |
chr11_70712647_70712798 | 10.66 |
Mir6925 |
microRNA 6925 |
6732 |
0.08 |
chr1_133265093_133265439 | 10.50 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
4190 |
0.17 |
chr10_8092375_8092549 | 10.41 |
Gm48614 |
predicted gene, 48614 |
71170 |
0.1 |
chr4_155245715_155246079 | 10.27 |
Faap20 |
Fanconi anemia core complex associated protein 20 |
3905 |
0.19 |
chr2_158153808_158154000 | 10.16 |
Tgm2 |
transglutaminase 2, C polypeptide |
7468 |
0.16 |
chr16_30603170_30603355 | 10.15 |
Fam43a |
family with sequence similarity 43, member A |
3539 |
0.24 |
chr16_22694632_22694783 | 10.13 |
Gm8118 |
predicted gene 8118 |
8513 |
0.18 |
chr14_78937878_78938029 | 10.08 |
Gm49016 |
predicted gene, 49016 |
9274 |
0.2 |
chr4_82306185_82306346 | 10.04 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
133145 |
0.05 |
chr8_94174559_94174710 | 10.02 |
Gm45774 |
predicted gene 45774 |
1222 |
0.26 |
chr6_59424988_59425182 | 9.95 |
Gprin3 |
GPRIN family member 3 |
1209 |
0.64 |
chr14_116448226_116448591 | 9.86 |
Gm38045 |
predicted gene, 38045 |
301807 |
0.01 |
chr17_24355260_24355582 | 9.78 |
Abca3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
3319 |
0.12 |
chr10_121125476_121125627 | 9.71 |
Gm48410 |
predicted gene, 48410 |
10306 |
0.16 |
chr10_63226846_63227134 | 9.58 |
Herc4 |
hect domain and RLD 4 |
16820 |
0.11 |
chr7_134497342_134497526 | 9.53 |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
1550 |
0.55 |
chr13_100532997_100533171 | 9.35 |
Ocln |
occludin |
19376 |
0.11 |
chr11_49088297_49088883 | 9.33 |
Gm12188 |
predicted gene 12188 |
47 |
0.79 |
chr10_68218812_68220021 | 9.24 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
59305 |
0.13 |
chr16_91146000_91146151 | 9.18 |
Gm49612 |
predicted gene, 49612 |
10599 |
0.1 |
chr3_83040525_83040907 | 9.15 |
Fgb |
fibrinogen beta chain |
9147 |
0.14 |
chr7_129793665_129794087 | 9.02 |
Gm44778 |
predicted gene 44778 |
39170 |
0.2 |
chr16_80273340_80273491 | 8.98 |
Gm23083 |
predicted gene, 23083 |
136063 |
0.05 |
chr16_13479439_13479612 | 8.83 |
Mir6365 |
microRNA 6365 |
8345 |
0.12 |
chr5_145990319_145990600 | 8.78 |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
1184 |
0.37 |
chr19_32282556_32283119 | 8.76 |
Sgms1 |
sphingomyelin synthase 1 |
5873 |
0.26 |
chr11_82803141_82803324 | 8.67 |
Lig3 |
ligase III, DNA, ATP-dependent |
4883 |
0.12 |
chr10_62795188_62795339 | 8.62 |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
2977 |
0.15 |
chr16_33892287_33892604 | 8.58 |
Itgb5 |
integrin beta 5 |
498 |
0.81 |
chr16_86817251_86817880 | 8.58 |
Gm32624 |
predicted gene, 32624 |
691 |
0.7 |
chr13_100849368_100849536 | 8.57 |
Gm29502 |
predicted gene 29502 |
2019 |
0.24 |
chr12_79403988_79404273 | 8.55 |
Rad51b |
RAD51 paralog B |
76777 |
0.1 |
chr16_78254868_78255025 | 8.50 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
410 |
0.81 |
chr12_91768973_91769144 | 8.46 |
Ston2 |
stonin 2 |
2112 |
0.29 |
chr1_133190582_133190733 | 8.39 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
9336 |
0.18 |
chr13_60267432_60267612 | 8.38 |
Gm24999 |
predicted gene, 24999 |
26150 |
0.16 |
chr2_164445108_164445423 | 8.32 |
Sdc4 |
syndecan 4 |
1378 |
0.23 |
chr5_118291975_118292126 | 8.31 |
Gm25076 |
predicted gene, 25076 |
25601 |
0.16 |
chr4_99028512_99028838 | 8.29 |
Angptl3 |
angiopoietin-like 3 |
2279 |
0.28 |
chr5_63893264_63893450 | 8.28 |
0610040J01Rik |
RIKEN cDNA 0610040J01 gene |
15881 |
0.17 |
chr13_101968109_101968528 | 8.24 |
Gm17832 |
predicted gene, 17832 |
47898 |
0.16 |
chr4_128950190_128950354 | 8.21 |
Azin2 |
antizyme inhibitor 2 |
11126 |
0.15 |
chr4_149798966_149799139 | 8.20 |
Gm13065 |
predicted gene 13065 |
5633 |
0.1 |
chr7_122665413_122665987 | 8.18 |
Cacng3 |
calcium channel, voltage-dependent, gamma subunit 3 |
4792 |
0.21 |
chr16_57127831_57128340 | 8.17 |
Tomm70a |
translocase of outer mitochondrial membrane 70A |
6382 |
0.18 |
chr1_86479051_86479408 | 8.14 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5570 |
0.15 |
chr13_119710019_119710182 | 8.13 |
Gm48342 |
predicted gene, 48342 |
5551 |
0.12 |
chr7_84201215_84201396 | 8.11 |
Gm44826 |
predicted gene 44826 |
9209 |
0.15 |
chr11_57983626_57984029 | 8.09 |
Gm12249 |
predicted gene 12249 |
10693 |
0.15 |
chr12_21144740_21144943 | 8.09 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
32887 |
0.16 |
chr18_23496939_23497187 | 8.05 |
Dtna |
dystrobrevin alpha |
228 |
0.96 |
chr10_94568025_94568184 | 8.02 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
7153 |
0.17 |
chr15_10245307_10245664 | 7.99 |
Prlr |
prolactin receptor |
4075 |
0.31 |
chr8_11148911_11149083 | 7.98 |
Gm44717 |
predicted gene 44717 |
249 |
0.91 |
chr11_50184843_50185222 | 7.93 |
Mrnip |
MRN complex interacting protein |
10125 |
0.11 |
chr6_113991518_113991701 | 7.90 |
Gm15083 |
predicted gene 15083 |
13180 |
0.17 |
chr10_8228115_8228580 | 7.81 |
Gm30906 |
predicted gene, 30906 |
52216 |
0.15 |
chr1_121323323_121323594 | 7.80 |
Insig2 |
insulin induced gene 2 |
267 |
0.9 |
chr8_116344914_116345106 | 7.77 |
1700018P08Rik |
RIKEN cDNA 1700018P08 gene |
12051 |
0.29 |
chr4_126017743_126017905 | 7.77 |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
6726 |
0.16 |
chr19_42551158_42551329 | 7.76 |
Gm16541 |
predicted gene 16541 |
11852 |
0.18 |
chr18_46630827_46631001 | 7.75 |
Gm3734 |
predicted gene 3734 |
107 |
0.96 |
chr10_96235051_96235242 | 7.68 |
4930459C07Rik |
RIKEN cDNA 4930459C07 gene |
8939 |
0.2 |
chr1_157073744_157073917 | 7.68 |
Gm28694 |
predicted gene 28694 |
19796 |
0.15 |
chr19_36629491_36629794 | 7.66 |
Hectd2os |
Hectd2, opposite strand |
3618 |
0.27 |
chr1_121350549_121350872 | 7.65 |
2210011K15Rik |
RIKEN cDNA 2210011K15 gene |
9190 |
0.16 |
chr5_102751686_102752074 | 7.61 |
Arhgap24 |
Rho GTPase activating protein 24 |
16891 |
0.28 |
chrX_164035471_164035631 | 7.60 |
Car5b |
carbonic anhydrase 5b, mitochondrial |
7554 |
0.2 |
chr18_60748821_60749236 | 7.59 |
Ndst1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
378 |
0.77 |
chr7_49358786_49358938 | 7.56 |
Nav2 |
neuron navigator 2 |
5859 |
0.24 |
chr8_18770899_18771050 | 7.56 |
Angpt2 |
angiopoietin 2 |
29412 |
0.16 |
chr2_148040189_148040578 | 7.56 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
180 |
0.94 |
chr11_69073563_69073728 | 7.56 |
Snord118 |
small nucleolar RNA, C/D box 118 |
218 |
0.73 |
chr13_35959638_35960013 | 7.53 |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
986 |
0.42 |
chr15_55819504_55819678 | 7.46 |
Sntb1 |
syntrophin, basic 1 |
86719 |
0.08 |
chr15_6709205_6709602 | 7.45 |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
1020 |
0.58 |
chr5_134550893_134551073 | 7.44 |
Gm42884 |
predicted gene 42884 |
1074 |
0.29 |
chr19_6243342_6243519 | 7.43 |
Atg2a |
autophagy related 2A |
1762 |
0.16 |
chr10_59537699_59537863 | 7.43 |
Gm10322 |
predicted gene 10322 |
78282 |
0.08 |
chr10_82758923_82759475 | 7.43 |
Nfyb |
nuclear transcription factor-Y beta |
1892 |
0.23 |
chr4_150825989_150826153 | 7.43 |
Gm13049 |
predicted gene 13049 |
338 |
0.86 |
chr3_65663297_65663473 | 7.43 |
Lekr1 |
leucine, glutamate and lysine rich 1 |
2843 |
0.19 |
chr13_77864889_77865040 | 7.41 |
Fam172a |
family with sequence similarity 172, member A |
156180 |
0.04 |
chr9_70827748_70828187 | 7.39 |
Gm3436 |
predicted pseudogene 3436 |
24609 |
0.16 |
chr7_140772355_140773139 | 7.35 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
8266 |
0.09 |
chr1_89620120_89620297 | 7.35 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
39972 |
0.14 |
chr8_88983561_88983712 | 7.30 |
Mir8110 |
microRNA 8110 |
41099 |
0.17 |
chr15_59391938_59392317 | 7.24 |
Nsmce2 |
NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase |
17840 |
0.18 |
chr17_5608184_5608335 | 7.23 |
Zdhhc14 |
zinc finger, DHHC domain containing 14 |
115702 |
0.05 |
chr5_75377802_75378010 | 7.23 |
Gm22084 |
predicted gene, 22084 |
5761 |
0.2 |
chr12_71719042_71719430 | 7.19 |
Gm47555 |
predicted gene, 47555 |
35149 |
0.17 |
chr15_3490987_3491164 | 7.18 |
Ghr |
growth hormone receptor |
19431 |
0.26 |
chr1_152677737_152678058 | 7.14 |
Gm15479 |
predicted gene 15479 |
9604 |
0.19 |
chr13_60173158_60174110 | 7.14 |
Gm48488 |
predicted gene, 48488 |
3048 |
0.21 |
chr7_76651093_76651386 | 7.12 |
2310001K20Rik |
RIKEN cDNA 2310001K20 gene |
40174 |
0.19 |
chr7_112170278_112170643 | 7.12 |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
11403 |
0.25 |
chr2_14250237_14250428 | 7.12 |
Mir511 |
microRNA 511 |
10671 |
0.17 |
chr3_79252925_79253290 | 7.10 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
33410 |
0.14 |
chr10_127653471_127653627 | 7.10 |
Stat6 |
signal transducer and activator of transcription 6 |
470 |
0.63 |
chr12_21166146_21166319 | 7.09 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
54278 |
0.1 |
chr17_86165279_86165510 | 7.07 |
Prkce |
protein kinase C, epsilon |
2391 |
0.3 |
chr3_52855388_52855549 | 7.06 |
Gm30292 |
predicted gene, 30292 |
57683 |
0.11 |
chr15_67423761_67424241 | 7.06 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
197232 |
0.03 |
chr2_152614332_152614489 | 7.05 |
Gm14163 |
predicted gene 14163 |
5236 |
0.08 |
chr4_149098915_149099084 | 7.05 |
Pex14 |
peroxisomal biogenesis factor 14 |
810 |
0.47 |
chr16_17217236_17217387 | 7.02 |
Rimbp3 |
RIMS binding protein 3 |
8708 |
0.09 |
chr8_114569124_114569455 | 7.01 |
Gm16116 |
predicted gene 16116 |
25611 |
0.19 |
chr1_180041926_180042077 | 6.98 |
Gm38169 |
predicted gene, 38169 |
20939 |
0.19 |
chr12_108304077_108304251 | 6.97 |
Hhipl1 |
hedgehog interacting protein-like 1 |
2106 |
0.27 |
chr6_128519043_128519655 | 6.96 |
Pzp |
PZP, alpha-2-macroglobulin like |
7354 |
0.09 |
chr2_25363590_25363748 | 6.96 |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
29 |
0.93 |
chr2_24742080_24742251 | 6.93 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
20882 |
0.16 |
chr5_9047464_9048021 | 6.92 |
Gm40264 |
predicted gene, 40264 |
12618 |
0.15 |
chr2_6321525_6321698 | 6.88 |
Usp6nl |
USP6 N-terminal like |
1056 |
0.43 |
chr5_63936466_63936784 | 6.87 |
Rell1 |
RELT-like 1 |
5711 |
0.18 |
chr11_94141055_94141236 | 6.82 |
B230206L02Rik |
RIKEN cDNA B230206L02 gene |
5485 |
0.22 |
chr3_115775909_115776067 | 6.81 |
Gm9889 |
predicted gene 9889 |
60838 |
0.1 |
chr5_35856357_35856514 | 6.80 |
Ablim2 |
actin-binding LIM protein 2 |
631 |
0.75 |
chr19_45445850_45446001 | 6.79 |
Btrc |
beta-transducin repeat containing protein |
417 |
0.83 |
chr18_65099329_65099521 | 6.77 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
16371 |
0.23 |
chr19_30128744_30128991 | 6.76 |
Gldc |
glycine decarboxylase |
16364 |
0.18 |
chr8_56589306_56589786 | 6.73 |
Fbxo8 |
F-box protein 8 |
1626 |
0.34 |
chr8_126838292_126838477 | 6.67 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
849 |
0.65 |
chr19_32685579_32685730 | 6.66 |
Atad1 |
ATPase family, AAA domain containing 1 |
9216 |
0.24 |
chr13_98594899_98595134 | 6.65 |
Gm4815 |
predicted gene 4815 |
18485 |
0.12 |
chr3_122417274_122417702 | 6.65 |
Bcar3 |
breast cancer anti-estrogen resistance 3 |
2269 |
0.24 |
chr10_44084446_44084597 | 6.63 |
Crybg1 |
crystallin beta-gamma domain containing 1 |
25743 |
0.17 |
chr4_33223953_33224209 | 6.62 |
Srsf12 |
serine and arginine-rich splicing factor 12 |
14818 |
0.14 |
chr6_115418714_115419284 | 6.62 |
Pparg |
peroxisome proliferator activated receptor gamma |
3067 |
0.27 |
chr3_65859331_65859533 | 6.61 |
Gm37131 |
predicted gene, 37131 |
5397 |
0.18 |
chr10_8086566_8086745 | 6.60 |
Gm48614 |
predicted gene, 48614 |
65363 |
0.12 |
chr5_146967227_146967378 | 6.59 |
Mtif3 |
mitochondrial translational initiation factor 3 |
3502 |
0.21 |
chr16_95741440_95741692 | 6.56 |
Gm6599 |
predicted gene 6599 |
12734 |
0.17 |
chr12_79140897_79141048 | 6.56 |
Arg2 |
arginase type II |
10195 |
0.09 |
chr14_46017259_46017572 | 6.55 |
Gm6580 |
predicted gene 6580 |
10013 |
0.17 |
chr15_25914259_25914426 | 6.53 |
Retreg1 |
reticulophagy regulator 1 |
3918 |
0.25 |
chr14_99616632_99616869 | 6.51 |
Gm49225 |
predicted gene, 49225 |
3266 |
0.27 |
chr8_126833896_126834272 | 6.51 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
5149 |
0.24 |
chr15_66183079_66183248 | 6.48 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
79909 |
0.09 |
chr6_97971154_97971321 | 6.45 |
Mitf |
melanogenesis associated transcription factor |
20555 |
0.25 |
chr14_51106134_51106584 | 6.45 |
Eddm3b |
epididymal protein 3B |
8067 |
0.08 |
chr1_82974456_82974623 | 6.45 |
Gm47955 |
predicted gene, 47955 |
14253 |
0.08 |
chr6_111600197_111600355 | 6.44 |
Gm22093 |
predicted gene, 22093 |
2976 |
0.4 |
chr2_50625194_50625394 | 6.43 |
Gm13484 |
predicted gene 13484 |
32773 |
0.19 |
chr10_24087275_24087474 | 6.43 |
Taar8b |
trace amine-associated receptor 8B |
4920 |
0.1 |
chr8_22848456_22848713 | 6.42 |
Kat6a |
K(lysine) acetyltransferase 6A |
10951 |
0.14 |
chr16_95449403_95449694 | 6.39 |
Erg |
ETS transcription factor |
9697 |
0.27 |
chr6_125575019_125575372 | 6.35 |
Vwf |
Von Willebrand factor |
8944 |
0.21 |
chr15_100628898_100629088 | 6.34 |
Smagp |
small cell adhesion glycoprotein |
6507 |
0.09 |
chr9_90108384_90108715 | 6.30 |
Morf4l1 |
mortality factor 4 like 1 |
5740 |
0.17 |
chr2_132684569_132684730 | 6.28 |
Shld1 |
shieldin complex subunit 1 |
2282 |
0.18 |
chrX_105934496_105934654 | 6.24 |
Atrx |
ATRX, chromatin remodeler |
5172 |
0.21 |
chr6_117843063_117843214 | 6.24 |
Zfp637 |
zinc finger protein 637 |
115 |
0.95 |
chr6_17178139_17178737 | 6.21 |
Gm4876 |
predicted gene 4876 |
6605 |
0.22 |
chr6_5517592_5517751 | 6.19 |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
21362 |
0.26 |
chr13_114466635_114466797 | 6.19 |
Fst |
follistatin |
7765 |
0.16 |
chr7_49477489_49477659 | 6.18 |
Gm38059 |
predicted gene, 38059 |
7862 |
0.24 |
chrX_130403672_130404070 | 6.17 |
Gm14984 |
predicted gene 14984 |
1652 |
0.52 |
chr16_23296908_23297059 | 6.17 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
6513 |
0.19 |
chr11_3161350_3161520 | 6.16 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3162 |
0.16 |
chr5_66798803_66798961 | 6.16 |
Limch1 |
LIM and calponin homology domains 1 |
52993 |
0.11 |
chr9_46230822_46231218 | 6.14 |
Apoa1 |
apolipoprotein A-I |
2299 |
0.14 |
chr2_83740744_83740901 | 6.13 |
Dnmt3l-ps1 |
DNA methyltransferase 3-like, pseudogene 1 |
4914 |
0.17 |
chr4_123576766_123577231 | 6.12 |
Macf1 |
microtubule-actin crosslinking factor 1 |
3938 |
0.22 |
chr7_138867340_138867520 | 6.12 |
Ppp2r2d |
protein phosphatase 2, regulatory subunit B, delta |
980 |
0.43 |
chr16_13258895_13259057 | 6.11 |
Mrtfb |
myocardin related transcription factor B |
2470 |
0.38 |
chr8_10873432_10873587 | 6.11 |
Gm32540 |
predicted gene, 32540 |
7323 |
0.11 |
chr3_81674937_81675101 | 6.09 |
Gm43346 |
predicted gene 43346 |
46657 |
0.17 |
chrX_60347501_60348092 | 6.09 |
Mir505 |
microRNA 505 |
46696 |
0.14 |
chr9_41306336_41306516 | 6.09 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
20651 |
0.16 |
chr8_84740975_84741146 | 6.07 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
18053 |
0.1 |
chr5_121950251_121950441 | 6.05 |
Cux2 |
cut-like homeobox 2 |
25425 |
0.15 |
chr5_46856306_46856720 | 6.05 |
Gm43092 |
predicted gene 43092 |
61833 |
0.16 |
chr9_72988766_72988933 | 6.05 |
Ccpg1 |
cell cycle progression 1 |
3230 |
0.1 |
chr2_59726132_59726380 | 6.04 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
16546 |
0.26 |
chr12_82743501_82743658 | 6.04 |
Gm22149 |
predicted gene, 22149 |
28877 |
0.22 |
chr14_50997940_50998134 | 6.03 |
Gm49038 |
predicted gene, 49038 |
962 |
0.33 |
chr8_115089778_115090403 | 6.03 |
Gm22556 |
predicted gene, 22556 |
37177 |
0.23 |
chr12_109987030_109987181 | 6.03 |
Gm34667 |
predicted gene, 34667 |
36768 |
0.09 |
chr8_120619240_120619416 | 6.02 |
1190005I06Rik |
RIKEN cDNA 1190005I06 gene |
15035 |
0.09 |
chr4_120070461_120070624 | 5.99 |
AL607142.1 |
novel protein |
5546 |
0.25 |
chr12_57446728_57447686 | 5.98 |
Gm16246 |
predicted gene 16246 |
2913 |
0.3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.6 | 17.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.7 | 10.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
2.7 | 8.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.6 | 5.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.6 | 5.1 | GO:0021564 | vagus nerve development(GO:0021564) |
2.5 | 2.5 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
2.4 | 12.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.4 | 12.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.4 | 7.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
2.3 | 11.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.3 | 9.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.1 | 4.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.1 | 6.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.1 | 6.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
2.1 | 6.2 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.9 | 5.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.9 | 9.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.9 | 9.5 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.9 | 9.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.9 | 5.6 | GO:0030242 | pexophagy(GO:0030242) |
1.8 | 9.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.8 | 5.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.8 | 14.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
1.8 | 5.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.8 | 5.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.8 | 5.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.7 | 5.2 | GO:0070384 | Harderian gland development(GO:0070384) |
1.7 | 1.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.7 | 5.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.6 | 4.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.6 | 1.6 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.6 | 6.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.6 | 4.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.6 | 3.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.5 | 6.2 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.5 | 4.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.5 | 4.5 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.5 | 9.0 | GO:0006477 | protein sulfation(GO:0006477) |
1.5 | 4.4 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.5 | 5.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.4 | 2.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.4 | 2.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.4 | 5.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.4 | 4.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.4 | 6.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.4 | 8.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.4 | 5.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.4 | 4.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.3 | 6.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.3 | 12.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.3 | 6.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.3 | 4.0 | GO:0015817 | histidine transport(GO:0015817) |
1.3 | 5.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.3 | 5.3 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.3 | 2.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.3 | 6.5 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.3 | 10.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.3 | 2.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.3 | 2.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.3 | 5.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.3 | 5.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.2 | 3.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.2 | 3.7 | GO:0097503 | sialylation(GO:0097503) |
1.2 | 4.9 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.2 | 3.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.2 | 2.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 4.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.2 | 3.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 3.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.2 | 5.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
1.2 | 2.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.1 | 3.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.1 | 3.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.1 | 2.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.1 | 3.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.1 | 5.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.1 | 2.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.1 | 5.5 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
1.1 | 5.5 | GO:0006901 | vesicle coating(GO:0006901) |
1.1 | 8.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.1 | 3.3 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.1 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 4.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 6.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 3.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 3.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.1 | 3.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.0 | 2.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.0 | 4.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.0 | 3.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.0 | 2.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.0 | 3.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.0 | 7.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.0 | 13.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.0 | 2.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.0 | 2.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.0 | 3.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.0 | 7.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
1.0 | 3.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.0 | 3.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.0 | 4.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.0 | 2.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.0 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.0 | 5.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.9 | 6.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 1.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.9 | 1.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.9 | 3.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.9 | 3.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.9 | 1.9 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.9 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.9 | 2.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.9 | 2.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 6.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.9 | 4.5 | GO:0002606 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.9 | 0.9 | GO:0015819 | lysine transport(GO:0015819) |
0.9 | 2.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.9 | 3.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.9 | 2.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.9 | 2.6 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.9 | 2.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 2.6 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.9 | 2.6 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.9 | 6.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.9 | 1.7 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.9 | 4.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 0.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.8 | 2.5 | GO:0003166 | bundle of His development(GO:0003166) |
0.8 | 5.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.8 | 5.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.8 | 3.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.8 | 2.5 | GO:0032898 | neurotrophin production(GO:0032898) |
0.8 | 2.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.8 | 1.6 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.8 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.8 | 4.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.8 | 7.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.8 | 5.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.8 | 8.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 1.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 4.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.8 | 2.4 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.8 | 1.6 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.8 | 1.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.8 | 2.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.8 | 2.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.8 | 2.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.8 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.8 | 3.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.8 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.8 | 2.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.8 | 2.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.8 | 3.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.8 | 3.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 1.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.8 | 0.8 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 0.8 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.8 | 3.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.8 | 1.5 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.8 | 2.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.7 | 0.7 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.7 | 1.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.7 | 3.7 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.7 | 2.2 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 2.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.7 | 4.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.7 | 2.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 1.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.7 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 1.5 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.7 | 5.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.7 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.7 | 2.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.7 | 6.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.7 | 2.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.7 | 4.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.7 | 2.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.7 | 2.9 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.7 | 5.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.7 | 2.1 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 3.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.7 | 0.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.7 | 1.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.7 | 2.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.7 | 4.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.7 | 2.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.7 | 8.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.7 | 6.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.7 | 2.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.7 | 3.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.7 | 1.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.7 | 0.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.7 | 2.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 6.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.7 | 1.4 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.7 | 2.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.7 | 1.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 2.7 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.7 | 14.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.7 | 2.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.7 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 5.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.7 | 2.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.7 | 6.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.6 | 7.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.6 | 1.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.6 | 3.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 4.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 0.6 | GO:0048382 | mesendoderm development(GO:0048382) |
0.6 | 7.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 0.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 0.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.6 | 4.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 5.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.6 | 1.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 1.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.6 | 2.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.6 | 1.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.6 | 1.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.6 | 6.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 0.6 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 1.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.6 | 1.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.6 | 5.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.6 | 1.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.6 | 2.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.6 | 13.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.6 | 0.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.6 | 0.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.6 | 1.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 2.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 1.8 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.6 | 2.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 4.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.6 | 1.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 3.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 1.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 2.4 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 1.2 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.6 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.2 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 4.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 1.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.6 | 5.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.6 | 1.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.6 | 1.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 1.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.6 | 0.6 | GO:0003097 | renal water transport(GO:0003097) |
0.6 | 1.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 1.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 3.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 4.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.6 | 1.2 | GO:0007343 | egg activation(GO:0007343) |
0.6 | 0.6 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.6 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.6 | 4.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.6 | 3.4 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.6 | 1.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.6 | 1.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.6 | 1.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 1.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 2.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 1.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 2.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.6 | 2.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 9.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.6 | 3.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.6 | 4.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.6 | 1.1 | GO:0042640 | anagen(GO:0042640) |
0.6 | 1.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 1.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.6 | 3.9 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.6 | 1.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 1.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 1.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 9.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 1.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.5 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 1.6 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.5 | 2.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.5 | 1.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 1.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 1.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.5 | 1.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 2.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 3.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.5 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 1.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.5 | 2.1 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.5 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 1.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 0.5 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.5 | 5.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 0.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 2.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.5 | 2.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 0.5 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.5 | 1.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 1.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 2.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 2.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 1.5 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.5 | 0.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.5 | 0.5 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) |
0.5 | 1.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 2.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.5 | 3.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 13.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 3.6 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 0.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.5 | 0.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.5 | 2.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 1.5 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.5 | 1.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.5 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.5 | 1.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 1.0 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 2.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 4.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.5 | 1.5 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.5 | 1.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 2.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 1.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 1.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 1.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.5 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 3.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 0.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.5 | 1.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 2.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 1.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 2.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.5 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 2.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.5 | 1.0 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.5 | 2.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 1.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 1.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 1.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.5 | 2.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 2.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 1.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 0.5 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.5 | 0.5 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.5 | 1.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.5 | 3.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 3.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 1.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 1.9 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.5 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 2.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.5 | 9.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.5 | 2.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.5 | 1.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.5 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 2.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 1.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 0.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.5 | 1.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.5 | 1.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.5 | 13.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 2.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.5 | 1.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.5 | 0.5 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.5 | 0.5 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.5 | 3.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.5 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.5 | 0.5 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.5 | 1.8 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.5 | 3.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 3.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.5 | 0.9 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 2.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.5 | 1.4 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.5 | 0.5 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.5 | 5.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 0.5 | GO:0051794 | regulation of catagen(GO:0051794) |
0.5 | 2.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 0.9 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 0.9 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.4 | 1.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 0.4 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.4 | 3.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 0.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 0.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) positive regulation of actin filament-based movement(GO:1903116) |
0.4 | 8.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 1.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 1.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.4 | 2.7 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.4 | 5.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.4 | 1.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 3.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.4 | 3.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 0.9 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.4 | 1.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.4 | 0.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 4.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 4.4 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 3.0 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.4 | 0.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.4 | 4.8 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.4 | 1.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 4.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.7 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.4 | 3.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 2.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 0.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 0.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.4 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 0.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 1.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 1.3 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 1.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 | 1.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 2.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.3 | GO:0051610 | serotonin uptake(GO:0051610) |
0.4 | 5.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 4.6 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 1.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 2.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.4 | 0.8 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.4 | 0.8 | GO:0010042 | response to manganese ion(GO:0010042) |
0.4 | 1.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.4 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 0.4 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.4 | 1.2 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 3.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 1.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 0.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 0.4 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 0.8 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 2.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 1.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 0.4 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.4 | 1.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 0.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.4 | 0.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.4 | 1.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 | 1.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.4 | 2.0 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.4 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 2.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.4 | 1.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 1.6 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.4 | 2.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.4 | 7.0 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.4 | 3.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 2.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 5.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 1.2 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.4 | 2.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 1.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.4 | 3.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 2.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.4 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 1.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 1.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.4 | 0.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 1.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 5.3 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.4 | 1.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.4 | 0.4 | GO:0035483 | gastric emptying(GO:0035483) |
0.4 | 1.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.4 | 0.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 2.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 3.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 0.4 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.4 | 0.4 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.4 | 1.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 1.9 | GO:0030220 | platelet formation(GO:0030220) |
0.4 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 0.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 2.9 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.4 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 5.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 0.4 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.4 | 5.5 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.4 | 1.1 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.4 | 1.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 0.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 5.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.4 | 2.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 0.7 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 1.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.4 | 2.9 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.4 | 1.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 1.4 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.4 | 1.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 0.4 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.4 | 2.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.4 | 0.4 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.4 | 3.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 1.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 1.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 1.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 2.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.4 | 1.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 1.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 0.4 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 2.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 1.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 8.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 1.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.4 | 1.4 | GO:0009838 | abscission(GO:0009838) |
0.4 | 2.1 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.4 | 2.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 0.7 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 0.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 1.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 1.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 5.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 1.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 4.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 4.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.3 | 1.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 10.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 3.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 0.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 0.7 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.3 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.7 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.3 | 1.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.3 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.3 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 0.7 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 1.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 3.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 3.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 2.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 0.3 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 0.7 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.3 | 1.7 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 0.3 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.3 | 3.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.3 | 0.3 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.3 | 0.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 2.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 1.6 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 1.6 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 2.3 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 0.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 1.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 1.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.3 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.3 | 4.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.3 | 1.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.3 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 1.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 1.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 2.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.9 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 1.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 23.5 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 2.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.3 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 1.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 1.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 2.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 0.3 | GO:0098659 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.3 | 0.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 1.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.8 | GO:0002209 | behavioral defense response(GO:0002209) |
0.3 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.3 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 0.3 | GO:1901879 | regulation of protein depolymerization(GO:1901879) |
0.3 | 1.2 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.3 | 1.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 2.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 1.5 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 0.3 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.3 | 1.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 1.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 2.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 0.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 2.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.6 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 5.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.3 | 0.6 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.3 | 0.9 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 1.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 0.6 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.3 | 1.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.6 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.3 | 0.3 | GO:0099612 | protein localization to juxtaparanode region of axon(GO:0071205) protein localization to axon(GO:0099612) |
0.3 | 0.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 1.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 11.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 2.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 1.4 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.3 | 2.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.3 | 0.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.3 | 2.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.3 | 0.3 | GO:0043476 | pigment accumulation(GO:0043476) |
0.3 | 0.8 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.3 | 0.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 1.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 0.6 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.3 | 1.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 2.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.3 | 1.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 1.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 1.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 3.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 0.8 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.3 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 1.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 1.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 0.8 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.9 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.3 | 3.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 1.4 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 1.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 0.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.3 | 1.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 0.3 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.3 | 0.5 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.3 | 0.3 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.3 | 0.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 0.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 2.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 1.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.9 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.3 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 2.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 2.6 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.3 | 0.5 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.3 | 0.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 1.3 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.3 | 0.3 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.3 | 1.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 0.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.3 | 0.8 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 0.8 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 1.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 1.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.3 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.3 | 2.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 3.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 0.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 2.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.3 | 0.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.3 | 0.3 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.3 | 0.5 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 2.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 1.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.3 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 1.0 | GO:0060039 | pericardium development(GO:0060039) |
0.3 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 0.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 0.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.2 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.2 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.5 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.2 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.0 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 1.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 1.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 1.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 2.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 1.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.5 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.5 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.2 | 0.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.2 | 1.2 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.2 | 1.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 1.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.2 | 1.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 1.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 3.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 1.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.5 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.2 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.2 | 0.7 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 6.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.2 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.2 | 0.7 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.5 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.9 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 2.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.9 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.9 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 2.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 1.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 2.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 2.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.5 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 1.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.5 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 1.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 2.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 14.9 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.2 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 3.6 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 1.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 2.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.4 | GO:0051972 | regulation of telomerase activity(GO:0051972) positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.2 | 0.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.5 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.2 | 0.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.4 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.2 | 1.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.2 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 2.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 1.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 1.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 8.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 1.3 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 1.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.5 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 7.0 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 1.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.4 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.2 | 0.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.2 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.2 | 0.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 0.2 | GO:0009415 | response to water(GO:0009415) |
0.2 | 1.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 0.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 0.4 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.2 | 3.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 1.5 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.2 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.2 | 1.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 0.8 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.2 | 0.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 0.8 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.4 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.2 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 1.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.2 | 2.7 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 2.7 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.2 | 0.8 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 1.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 3.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 2.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 2.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.2 | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.2 | 4.3 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.2 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.2 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 2.6 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 3.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 0.2 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 1.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.8 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 2.6 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 2.2 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.2 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 1.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 3.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 2.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 2.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 2.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.6 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 2.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 1.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.0 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.2 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 4.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.4 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 1.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 2.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.2 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 6.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 1.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.2 | 0.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 1.3 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 2.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 0.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 8.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.6 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 1.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 1.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 1.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.4 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.2 | 0.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 1.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 0.9 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 0.4 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.2 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.2 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 1.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.4 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 15.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.5 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.2 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.5 | GO:0006833 | water transport(GO:0006833) |
0.2 | 1.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.7 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 0.4 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 0.5 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 2.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.2 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 1.1 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 2.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 3.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.9 | GO:0098751 | osteoclast development(GO:0036035) bone cell development(GO:0098751) |
0.2 | 3.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 2.7 | GO:0007588 | excretion(GO:0007588) |
0.2 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.9 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 4.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.2 | 0.3 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.2 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.2 | 1.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 4.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.2 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.2 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.5 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 2.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.2 | 0.2 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.2 | 0.2 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 1.9 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.2 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.2 | 1.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.3 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 3.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 2.8 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.2 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.2 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.2 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 0.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 1.0 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 0.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 1.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.2 | 2.0 | GO:0048332 | mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
0.2 | 0.8 | GO:0090102 | cochlea development(GO:0090102) |
0.2 | 0.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 3.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 2.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.2 | 0.5 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.3 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 1.3 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 0.8 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 0.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 0.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 1.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 0.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.2 | GO:0051580 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) regulation of neurotransmitter uptake(GO:0051580) |
0.2 | 1.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 0.8 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.2 | 0.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.2 | 0.3 | GO:0060026 | convergent extension(GO:0060026) |
0.2 | 1.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 1.8 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 2.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.2 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 1.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.6 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.3 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.4 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 2.3 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 0.9 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 1.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.3 | GO:0009130 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.7 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.3 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.3 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.1 | 1.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.1 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 3.4 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 3.1 | GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) |
0.1 | 1.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.7 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.3 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 0.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 1.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.5 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 1.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 2.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.3 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.7 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 1.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.7 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.5 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 0.4 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.1 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 1.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 6.3 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.4 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.3 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 2.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 1.5 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 2.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 3.9 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 2.7 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.4 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.1 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.1 | 6.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.5 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.7 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 2.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.2 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 0.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 2.1 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 2.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 1.1 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.9 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.1 | 0.4 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.3 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 1.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 3.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 1.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0006837 | serotonin transport(GO:0006837) |
0.1 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.6 | GO:0045058 | T cell selection(GO:0045058) |
0.1 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 1.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 1.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.4 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.1 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) positive regulation of oxidative stress-induced cell death(GO:1903209) positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 4.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.4 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.1 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 1.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 1.1 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.2 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 6.1 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.6 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.2 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.2 | GO:0071440 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) |
0.1 | 0.6 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.6 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 1.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 1.1 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.1 | 0.3 | GO:0090220 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic telomere clustering(GO:0045141) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 1.3 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.7 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.3 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.1 | 0.4 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 2.7 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 2.1 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.6 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.1 | 0.9 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 1.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.1 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 1.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 1.1 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.5 | GO:0098534 | centriole assembly(GO:0098534) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 1.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 1.3 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 3.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.4 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.2 | GO:0050716 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.4 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.2 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 1.2 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.1 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.2 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.3 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 1.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.4 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.0 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.0 | GO:1900408 | negative regulation of cellular response to oxidative stress(GO:1900408) negative regulation of response to oxidative stress(GO:1902883) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 1.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.3 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.4 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.2 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 1.3 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.0 | 0.0 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.0 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.8 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.0 | GO:0072575 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.3 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 1.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.2 | GO:0008306 | associative learning(GO:0008306) |
0.0 | 0.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 0.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0003209 | cardiac atrium morphogenesis(GO:0003209) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.0 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.0 | 0.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 2.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.0 | GO:0050920 | regulation of chemotaxis(GO:0050920) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.0 | 0.0 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0035989 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.0 | 0.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.4 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.9 | 20.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.4 | 2.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.4 | 14.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.2 | 8.6 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.7 | 5.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.7 | 12.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.6 | 4.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 3.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.5 | 5.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.4 | 1.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.3 | 5.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.2 | 3.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.2 | 7.0 | GO:0042627 | chylomicron(GO:0042627) |
1.2 | 1.2 | GO:0005652 | nuclear lamina(GO:0005652) |
1.2 | 4.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 6.6 | GO:0005767 | secondary lysosome(GO:0005767) |
1.1 | 1.1 | GO:0042585 | germinal vesicle(GO:0042585) |
1.1 | 10.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.0 | 3.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.0 | 3.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.0 | 3.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 11.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 7.9 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 2.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 5.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.9 | 11.7 | GO:0038201 | TOR complex(GO:0038201) |
0.9 | 2.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.9 | 3.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.8 | 2.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.8 | 6.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.8 | 2.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 3.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.8 | 3.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.8 | 2.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.8 | 4.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 3.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.8 | 2.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 2.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 10.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.7 | 4.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 3.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.7 | 5.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 3.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 2.5 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 2.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 4.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.6 | 1.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 0.6 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.6 | 1.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 1.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 5.1 | GO:0002102 | podosome(GO:0002102) |
0.6 | 3.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 1.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 7.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.6 | 8.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 1.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.5 | 1.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 1.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 2.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 3.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 2.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.5 | 4.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 26.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.5 | 11.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.5 | 1.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 8.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 2.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 2.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 1.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 3.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 1.9 | GO:0035363 | histone locus body(GO:0035363) |
0.5 | 3.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 2.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 12.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 3.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.5 | 2.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 6.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 6.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 3.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 7.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 3.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 3.9 | GO:0043218 | compact myelin(GO:0043218) |
0.4 | 1.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 2.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 1.2 | GO:0005770 | late endosome(GO:0005770) |
0.4 | 4.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 2.1 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 1.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 3.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.4 | 2.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 9.9 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 4.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 1.2 | GO:0030425 | dendrite(GO:0030425) |
0.4 | 3.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 1.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 3.1 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 1.9 | GO:0033503 | HULC complex(GO:0033503) |
0.4 | 11.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 2.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 1.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 5.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 4.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 2.6 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 5.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 3.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 2.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 1.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 1.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 2.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 2.1 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.1 | GO:0002177 | manchette(GO:0002177) |
0.3 | 3.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 14.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 16.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 13.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 1.4 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.3 | 16.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 4.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 2.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 2.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 5.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 2.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 3.6 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 5.3 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 2.3 | GO:0000801 | central element(GO:0000801) |
0.3 | 5.8 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 2.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.6 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 2.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 1.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 4.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 2.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 1.8 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 1.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 7.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 0.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 0.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 2.1 | GO:0098552 | side of membrane(GO:0098552) |
0.3 | 2.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 0.9 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.2 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.3 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 3.5 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 3.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.4 | GO:0044297 | cell body(GO:0044297) |
0.3 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 5.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 2.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 2.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 2.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 1.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 1.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 4.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 2.9 | GO:0001741 | XY body(GO:0001741) |
0.3 | 1.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 5.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 3.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 0.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 4.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.3 | 7.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.3 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 0.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 0.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.3 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 2.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 3.4 | GO:0071010 | prespliceosome(GO:0071010) |
0.2 | 1.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 4.1 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 3.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 2.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 2.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 9.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 4.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 3.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 2.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 19.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 11.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 3.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.2 | 2.7 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 6.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 4.4 | GO:0031674 | I band(GO:0031674) |
0.2 | 4.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.7 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 4.6 | GO:0031256 | leading edge membrane(GO:0031256) |
0.2 | 1.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 2.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 2.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 3.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 2.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 3.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.4 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.8 | GO:0097458 | neuron part(GO:0097458) |
0.2 | 4.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 5.7 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 13.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 3.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 4.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 1.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 1.3 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 1.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 8.0 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 1.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 7.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 3.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 8.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.9 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 3.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 3.3 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 4.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.4 | GO:0030054 | cell junction(GO:0030054) |
0.2 | 3.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 1.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 4.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 1.6 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.2 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 3.6 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 2.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 14.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 2.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 8.4 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 2.2 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.2 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 9.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 1.1 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 2.0 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 4.4 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.2 | GO:0043234 | protein complex(GO:0043234) |
0.1 | 0.9 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.0 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 4.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 3.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 3.8 | GO:0045202 | synapse(GO:0045202) |
0.1 | 4.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 40.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 7.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.7 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.8 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 127.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.4 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 1.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.9 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 3.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 37.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 6.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 9.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.4 | GO:0001940 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.1 | 5.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 2.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.5 | GO:0043205 | fibril(GO:0043205) |
0.1 | 3.1 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 118.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 9.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 5.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 0.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0099738 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.1 | 2.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 4.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.3 | GO:0044304 | main axon(GO:0044304) |
0.1 | 6.0 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 7.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 8.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 1.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.1 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.1 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 10.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 27.6 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 1.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 1.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 8.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 11.2 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 3.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 3.3 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 106.4 | GO:0005886 | plasma membrane(GO:0005886) |
0.1 | 38.0 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 49.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 9.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 4.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 2.2 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 3.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 122.5 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 6.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 174.0 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 94.3 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 74.7 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.4 | 9.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.3 | 9.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.1 | 10.5 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
2.0 | 6.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.9 | 15.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.9 | 9.5 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
1.8 | 1.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.8 | 5.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.8 | 10.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.7 | 5.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.7 | 10.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.6 | 6.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.6 | 4.7 | GO:0043398 | HLH domain binding(GO:0043398) |
1.6 | 6.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.5 | 3.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.5 | 11.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.4 | 4.3 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.4 | 4.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.4 | 5.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.4 | 5.6 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.4 | 9.6 | GO:0018637 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.3 | 5.3 | GO:0031433 | telethonin binding(GO:0031433) |
1.2 | 3.7 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 1.2 | GO:0035197 | siRNA binding(GO:0035197) |
1.2 | 1.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.2 | 8.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.2 | 1.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
1.2 | 4.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.1 | 3.4 | GO:0050693 | LBD domain binding(GO:0050693) |
1.1 | 20.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.1 | 4.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.1 | 3.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.1 | 4.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.1 | 4.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.1 | 5.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.1 | 3.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 5.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.0 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 4.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.0 | 3.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.0 | 3.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 2.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
1.0 | 4.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.0 | 6.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.0 | 5.7 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.9 | 12.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 5.6 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.9 | 2.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.9 | 4.4 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.9 | 0.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 2.6 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.9 | 10.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.9 | 5.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.9 | 4.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.9 | 2.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.9 | 3.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 1.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.9 | 8.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.9 | 0.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.9 | 1.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.8 | 2.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 1.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.8 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.8 | 4.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.8 | 3.2 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.8 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 6.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.8 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 2.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.8 | 2.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.8 | 2.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 2.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 3.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 11.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.8 | 1.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.8 | 4.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.8 | 4.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.8 | 3.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 2.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.8 | 7.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 4.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 4.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.7 | 4.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 2.2 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 7.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 6.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 11.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 1.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.7 | 2.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 3.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.7 | 3.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 2.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 9.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 4.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 2.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 2.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.7 | 5.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 5.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 1.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 0.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 2.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 1.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 8.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 2.0 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.7 | 7.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 1.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.7 | 3.3 | GO:0035473 | lipase binding(GO:0035473) |
0.7 | 3.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.7 | 2.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.7 | 2.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 3.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.6 | 1.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 3.8 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 9.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.6 | 1.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 2.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 0.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.6 | 8.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 7.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.6 | 2.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.6 | 5.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.6 | 7.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 1.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 1.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 2.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 2.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 3.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 1.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 2.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 2.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 1.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 1.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 0.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.6 | 1.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 3.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 1.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.6 | 2.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.6 | 9.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.6 | 9.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 6.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.6 | 1.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 2.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 2.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 1.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.5 | 1.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 4.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.5 | 2.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 4.8 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 4.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 10.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 1.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 1.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 28.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 4.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 1.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 2.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 1.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 3.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 1.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.5 | 1.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 3.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 1.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 2.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 4.4 | GO:0048038 | quinone binding(GO:0048038) |
0.5 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 6.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.5 | 1.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 1.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 5.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 3.8 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.5 | 1.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 7.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 1.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 1.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 0.5 | GO:0046977 | TAP binding(GO:0046977) |
0.5 | 2.3 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 6.0 | GO:0016918 | retinal binding(GO:0016918) |
0.5 | 1.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 4.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.5 | 4.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 2.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.4 | 9.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 3.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 2.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 2.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 12.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.4 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 3.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 1.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 3.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 1.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 1.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 1.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 1.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 2.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 14.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 2.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 1.7 | GO:0051427 | hormone receptor binding(GO:0051427) |
0.4 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 5.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 4.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 7.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 2.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 15.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.6 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.4 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 3.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 3.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 1.6 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 1.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 2.0 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.4 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 4.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 6.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 1.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 6.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.4 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 11.0 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.4 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 7.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 15.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 1.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 3.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 11.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 3.3 | GO:0043141 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) ATP-dependent 5'-3' DNA helicase activity(GO:0043141) phosphocholine hydrolase activity(GO:0044606) |
0.4 | 3.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.4 | 0.4 | GO:0032142 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 1.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 6.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 1.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.4 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 0.4 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.4 | 0.4 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.3 | 1.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 3.8 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.3 | 2.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 7.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 2.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 1.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 2.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 3.7 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 0.3 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.3 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 2.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.3 | 1.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 2.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 2.3 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 2.6 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 1.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 3.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 4.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 1.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 1.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 3.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 12.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 4.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 2.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 1.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 2.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 9.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 0.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 2.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 1.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 2.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 6.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 1.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 14.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 2.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 0.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 4.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 2.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 4.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.3 | 1.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 4.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 1.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 0.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 0.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 2.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 2.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 2.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 2.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 53.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 1.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 1.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 3.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 5.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 7.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 0.5 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 1.6 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 0.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 1.3 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 4.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.1 | GO:0102345 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 3.4 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 1.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 3.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 2.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 3.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 4.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 5.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 1.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 2.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 1.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 2.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 6.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 6.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 2.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 6.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 2.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 8.4 | GO:0080131 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.2 | 1.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 1.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.6 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.2 | 1.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 4.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 5.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 1.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 6.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 0.7 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 1.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 6.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 2.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 4.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 11.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 3.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.2 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 3.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.9 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 3.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 3.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 0.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 1.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 4.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 2.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 2.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 6.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 4.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 9.7 | GO:0060090 | binding, bridging(GO:0060090) |
0.2 | 1.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 1.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 1.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 3.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 2.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 2.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 3.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 0.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 18.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 3.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 9.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 0.7 | GO:0042834 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) peptidoglycan binding(GO:0042834) |
0.2 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 1.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 8.0 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 8.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 2.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 2.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 2.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 2.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 2.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 1.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.7 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 2.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 31.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 1.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 2.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.2 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.2 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 1.0 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.2 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.5 | GO:0048403 | neurotrophin binding(GO:0043121) brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.8 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 4.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.2 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 8.5 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 2.8 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 11.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.2 | 0.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 3.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 5.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 9.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 1.8 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 3.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 4.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 7.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 3.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.3 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 4.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 3.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 3.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 8.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 1.2 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 2.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 12.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 5.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 2.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 2.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 2.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 2.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 6.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 5.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 2.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 1.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 12.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 6.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 1.0 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0015605 | nucleotide transmembrane transporter activity(GO:0015215) organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 2.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 3.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.8 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 4.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.9 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 3.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 5.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 14.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 3.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 10.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 8.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 5.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 7.8 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.1 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 1.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 2.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 5.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 1.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.5 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 4.5 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 4.0 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 3.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 2.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 2.7 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 11.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 9.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.4 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
0.0 | 6.5 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 1.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.0 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 23.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 7.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 12.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.8 | 23.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.7 | 9.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.7 | 7.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 24.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 7.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.6 | 5.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 3.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 18.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 5.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.6 | 10.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.6 | 3.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 35.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 5.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 8.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 6.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 12.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 8.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.5 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 20.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 5.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 9.1 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 3.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 3.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 10.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 2.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 2.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 8.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 6.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 3.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 0.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 2.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 2.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 12.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 5.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 4.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 3.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 2.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 6.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 11.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 14.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 1.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 10.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 4.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 3.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 5.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 3.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 1.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 3.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 9.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 5.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 2.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 2.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 1.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 8.6 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 10.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 10.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 9.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 12.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 6.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 10.0 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 2.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 3.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 1.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 7.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 2.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 10.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 1.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 50.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 5.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 2.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 6.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 5.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 3.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 3.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 2.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 7.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 5.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 4.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 1.2 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 1.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 2.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 3.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 18.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 4.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 15.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 3.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.1 | 11.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
1.7 | 3.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.5 | 20.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.4 | 14.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.4 | 1.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.3 | 1.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.1 | 14.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.0 | 15.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 4.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.9 | 11.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 10.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.9 | 1.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.9 | 6.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.9 | 4.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 6.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 4.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.7 | 8.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 11.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 9.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.7 | 8.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.7 | 11.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.7 | 3.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 7.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.6 | 14.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 16.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 7.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 4.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 13.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.6 | 5.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 6.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 1.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.5 | 11.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 3.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 8.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 7.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.5 | 2.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.5 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 19.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 1.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 1.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 3.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 4.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 9.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.5 | 0.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.5 | 5.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 4.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 9.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 4.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 0.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.4 | 12.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 3.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 2.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 12.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 2.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 7.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 3.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 2.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 4.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 10.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 3.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 3.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 5.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 3.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 25.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 6.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 3.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 15.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 4.8 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.4 | 5.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 3.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 3.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 5.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 3.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 4.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 8.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 2.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 7.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 4.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.4 | 8.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 3.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 15.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 8.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 2.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 6.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 3.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 1.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 4.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 3.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 5.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 3.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 1.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 9.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 4.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 3.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 5.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 7.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 1.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 3.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.3 | 1.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 11.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 3.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.3 | 3.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 3.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 2.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 8.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.9 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.2 | 2.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 5.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 5.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 1.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 3.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 2.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 1.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 2.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 3.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 2.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 4.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 7.7 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 1.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 6.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 3.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 2.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 7.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 2.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 4.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 4.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 4.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.3 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.2 | 1.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 14.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 4.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 8.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 17.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 4.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 7.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 7.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 3.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 4.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.0 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 6.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 3.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.2 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 5.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.7 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.0 | 1.0 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 1.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 1.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.0 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |